JG
NVAX icon

Jefferies Group’s Novavax NVAX Stock Holding History

Jefferies Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.27K Buy
+70
New +$3.03K ﹤0.01% 1594
2022
Q2 		– Sell
-1,240
Closed -$64.2K – 1764
2022
Q1 		$91.3K Buy
+1,240
New +$111K ﹤0.01% 1349
2021
Q4 		– Sell
-2,500
Closed -$430K – 1891
2021
Q3 		$518K Buy
2,500
+1,126
+82% +$248K ﹤0.01% 1216
2021
Q2 		$292K Buy
1,374
+847
+161% +$155K ﹤0.01% 1313
2021
Q1 		$95.5K Sell
527
-34,452
-98% -$6.87M ﹤0.01% 1449
2020
Q4 		$3.9M Buy
34,979
+591
+2% +$62.8K 0.03% 495
2020
Q3 		$3.73M Buy
34,388
+6,613
+24% +$806K 0.04% 359
2020
Q2 		$2.31K Buy
27,775
+27,583
+14,366% +$1.05M 0.03% 501
2020
Q1 		$3K Buy
+192
New +$1.63K ﹤0.01% 1981
2019
Q2 		– Sell
-818
Closed -$9K – 2772
2019
Q1 		$9K Buy
818
+689
+534% +$21.8K ﹤0.01% 2266
2018
Q4 		$5K Sell
129
-4,875
-97% -$189K ﹤0.01% 2100
2018
Q3 		$188K Buy
5,004
+4,439
+786% +$125K ﹤0.01% 2125
2018
Q2 		$15K Buy
+565
New +$19.1K ﹤0.01% 2243
2016
Q3 		– Sell
-2,350
Closed -$303K – 2386
2016
Q2 		$342K Buy
+2,350
New +$269K ﹤0.01% 1605
2015
Q4 		– Sell
-10,526
Closed -$1.49M – 2477
2015
Q3 		$1.49M Buy
+10,526
New +$2.36M 0.01% 1027

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jefferies Group's NVAX Position: Q3 2022 in Review

Jefferies Group opened a new position in Novavax (NVAX) in Q3 2022: 70 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #1594 among its holdings. This is a return to the name: Jefferies Group previously reported a position in NVAX as recently as Q1 2022.

Jefferies Group first reported a position in NVAX in Q3 2015 and has held it in 15 quarters since. The position peaked at $3.9M in Q4 2020. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Jefferies Group held 70 shares of Novavax worth $1.27K as of Q3 2022.
  • Novavax was a new Jefferies Group position in Q3 2022.
  • Novavax made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1594 holding.
  • Jefferies Group first reported a position in Novavax in Q3 2015 and has held it in 15 quarters since.
  • Jefferies Group's Novavax position peaked at $3.9M in Q4 2020.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.